Is Nuvation Bio Inc. (NUVB) a Buy, Sell, or Hold?
NYSE : NUVB
Nuvation Bio Inc. — Stock Grades
$6.37 USD
-$0.07 (-1.01%)
- Volume
- 4.89M
- Average Volume
- 6.25M
- Market Capitalization
- $2.21B
- P/E Ratio
- -15.01
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $9.75
- Year Low
- $2.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.44
NUVB Stock Grades
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-07-27 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2026-07-23 | Wedbush | Outperform | Outperform | Maintain |
| 2026-07-07 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-07-07 | Truist Securities | Buy | Buy | Maintain |
| 2026-05-05 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2026-05-05 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-05-05 | Wedbush | Outperform | Outperform | Maintain |
| 2026-04-16 | Wedbush | Outperform | Outperform | Maintain |
| 2026-04-02 | Wedbush | Outperform | Outperform | Maintain |
| 2026-03-27 | Wedbush | Outperform | Outperform | Maintain |
| 2026-03-03 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-03-03 | UBS | Neutral | Neutral | Maintain |
| 2026-02-10 | Wedbush | Outperform | Outperform | Maintain |
| 2026-01-21 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-01-12 | HC Wainwright & Co. | Buy | Buy | Maintain |